Caxton Associates (New York)’s C4 Therapeutics CCCC Stock Holding History

Caxton Associates (New York)’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$75.6K	Hold
2024 Q3	$120K	Hold
2024 Q2	$97K	Hold
2024 Q1	$172K	Buy
2023 Q3	–	Sell
2023 Q2	$73.5K	Sell
2023 Q1	$122K	Buy